Synthesis and Functional Investigations of Computer Designed Novel Cladribine-Like Compounds for the Treatment of Multiple Sclerosis

Autor: Yavuz, S., Çetin, A., Akdemir, A., Doyduk, D., Dişli, A., Çelik Turgut, G., Şen, Alaattin
Jazyk: angličtina
Rok vydání: 2017
Předmět:
synthesis
protein p53
T-Lymphocytes
Apoptosis
multiple sclerosis
Raji cell line
T lymphocyte
4 fluoro n [9 (4 hydroxy 5 (hydroxymethyl)tetrahydrofuran 2 yl) 9h purin 6 yl)benzamide
antineoplastic agent
comparative study
DNA strand breakage
B-Lymphocytes
computer aided design
drug effect
Cell Cycle
cell line
unclassified drug
Molecular Docking Simulation
priority journal
fluorescence
antiinflammatory agent
signal transduction
Immunosuppressive Agents
DNA repair
cladribine derivative
Antineoplastic Agents
cladribine
chemistry
Article
Multiple Sclerosis
Relapsing-Remitting

DNA fragmentation assay
drug mechanism
gene expression profiling
computer simulation
double stranded DNA break
Humans
human
structure activity relation
B lymphocyte
human cell
DNA Breaks
2 amino 2 [4 (6 amino 9h purin 9 yl)butyl]propane 1
3 diol

molecular docking
immunosuppressive agent
CCRF-CEM cell line
CCRF-CEM cells
RAJI cells
DNA damage
drug synthesis
Molecular modeling studies
immunomodulating agent
metabolism
ATR protein
DOI: 10.1002/ardp.201700185
Popis: Cladribine (2-CdA) is used as an anti-cancer drug but is currently studied as a potential treatment for use in relapsing-remitting multiple sclerosis (MS). In this study, we computer designed, synthesized, and characterized two novel derivatives of 2-CdA, K1–5d and K2–4c, and investigated their underlying mechanism of beneficial effect using the CCRF-CEM and RAJI cell lines. For this purpose, we first determined their effect on MS and DNA damage and repair-related gene expression profiles using custom arrays along with 2-CdA treatment at non-toxic doses. Then, we determined whether cells underwent apoptosis after treatment with 2-CdA, K1–5d, and K2–4c in CCRF-CEM and RAJI cells, using the DNA fragmentation assay. It was found that both derivatives modulated the expression of the pathway-related genes that are important in inflammatory signaling, apoptosis, ATM/ATR, double-strand break repair, and the cell cycle. Furthermore, 2-CdA, K1–5d, and K2–4c significantly activated apoptosis in both cell lines. In summary, our data demonstrate that although both derivatives act as anti-inflammatory and apoptotic agents, inducing the accumulation of DNA strand breaks and activating the ultimate tumor suppressor p53 in T and B lymphocytes, the K1–5d derivative has shown more promising activities for further studies. © 2017 Deutsche Pharmazeutische Gesellschaft
Databáze: OpenAIRE